Kanglaite 200ml is injected once a day from Monday to Friday during radiotherapy.

Head and Neck Cancer

Radiotherapy

Kanglaite injection 200ml is injected intravenous from the first day to the last day of radiotherapy.

Kanglaite

Jing JL, Li XL, Nan YQ. Advances in the study of the effect of Kanglaite injection on tumor therapy. Chinese Remedies & Clinics, 2013;13(11):1447-1448 (in Chinese).

Guo Y, Li DP. Protective effects of Kanglaite injection on hematopoiesis and liver and kidney damage caused by three anticancer drugs. Chinese journal of modern applied phaemacy.1998;15(6):61-62(in Chinese).

Wang WD, Sun SP, Wang XD. Influence of KLT on Radiotherapy Effect of Patients with Advanced Nasopharyngeal Carcinoma. China Journal of Cancer Prevention and Treatment,2003:10(6): 635-637(in Chinese).

Ren ZP, et al. The therapeutic effects of the combined therapy with kanglaite injection and radiotherapy on nasopharyngea carcinoma among aged cases. Chinese Journal of Otorhinolaryngology of Integrated Traditional and Western Medici 2005;13(6)

First Affiliated Hospital of Harbin Medical University

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

the incidence rate of radiation mucositis assessed by CTCAE v4

the incidence rate of non-hematologic toxicity side events assessed by CTCAE v4

the incidence rate of hematologic toxicity side events assessed by CTCAE v4

the nutritional status scored by patient-generated subjective global assessment

the quality of life scored by EORTC QLQ-C30 questionnaire

the quality of life scored by EORTC QLQ-H&N35 questionnaire

The investigators have no other clinical trial about cancer of head and neck

Kanglaite injection + Radiotherapy ± Chemotherapy

mucositis/triglyceride

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

La base de données d'herbes médicinales la plus complète soutenue par la science